Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies
Cell Host & Microbe · 2023-10 · 31 (10) · 1574-1592
DOI: 10.1016/j.chom.2023.09.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2023-10. Verfasst von Vishnu Raman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA, USA; Ernest Pharmaceuticals, LLC, Hadley, MA, USA. Hauptthemen laut MEDLINE: Host Microbial Interactions, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 215 Literaturangaben. Gefördert von: National Science Foundation, University of Massachusetts Amherst, National Cancer Institute.
Abstract (Originalsprache)
Many systemically administered cancer therapies exhibit dose-limiting toxicities that reduce their effectiveness. To increase efficacy, bacterial delivery platforms have been developed that improve safety and prolong treatment. Bacteria are a unique class of therapy that selectively colonizes most solid tumors. As delivery vehicles, bacteria have been genetically modified to express a range of therapies that match multiple cancer indications. In this review, we describe a modular "build-a-bug" method that focuses on five design characteristics: bacterial strain (chassis), therapeutic compound, delivery method, immune-modulating features, and genetic control circuits. We emphasize how fundamental research into gut microbe pathogenesis has created safe bacterial therapies, some of which have entered clinical trials. The genomes of gut microbes are fertile grounds for discovery of components to improve delivery and modulate host immune responses. Future work coupling these delivery vehicles with insights from gut microbes could lead to the next generation of microbial cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA, USA; Ernest Pharmaceuticals, LLC, Hadley, MA, USA.
- Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA, USA.
- Ernest Pharmaceuticals, LLC, Hadley, MA, USA.
- Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA, USA; Molecular and Cell Biology Program, University of Massachusetts, Amherst, Amherst, MA, USA; Institute for Applied Life Science,…
Förderung
- National Science Foundation
- University of Massachusetts Amherst
- National Cancer Institute
- National Institutes of Health
- US Department of Defense
Zitieren
APA
Raman, V., Deshpande, C. P., Khanduja, S., Howell, L. M., Van Dessel, N., & Forbes, N. S. (2023). Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies. Cell Host & Microbe, 31(10), 1574-1592. https://doi.org/10.1016/j.chom.2023.09.006
Vancouver
Raman V, Deshpande CP, Khanduja S, Howell LM, Van Dessel N, Forbes NS. Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies. Cell Host & Microbe. 2023;31(10):1574-1592. doi:10.1016/j.chom.2023.09.006
BibTeX
@article{Raman2023,
author = {Raman, Vishnu and Deshpande, Chinmay P and Khanduja, Shradha and Howell, Lars M and Van Dessel, Nele and Forbes, Neil S},
title = {Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies},
journal = {Cell Host & Microbe},
year = {2023},
volume = {31},
number = {10},
pages = {1574--1592},
doi = {10.1016/j.chom.2023.09.006}
}
EUVIMED